Lixte Biotechnology Holdings Inc Stock Ownership - Who owns Lixte Biotechnology Holdings?

Insider buying vs selling

Have Lixte Biotechnology Holdings Inc insiders been buying or selling?
Der Baan Bastiaan Jeroen VanDirector2022-12-3010,000$0.49
Der Baan Bastiaan Jeroen VanDirector2022-12-3010,000$4.90
Der Baan Bastiaan Jeroen VanDirector2022-12-3010,000$4.90
Rene BernardsDirector2022-12-1515,000$0.51
Rene BernardsDirector2022-12-1210,000$0.61
Eric FormanVice President and COO2022-12-091,112$0.63
Eric FormanVice President and COO2022-12-0910,000$0.60
Eric FormanVice President and COO2022-12-095,000$0.63
Eric FormanVice President and COO2022-11-222,484$0.56
Regina BrownDirector2022-11-212,400$0.57

1 of 2

LIXT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LIXT insiders and whales buy or sell their stock.

LIXT Shareholders

What type of owners hold Lixte Biotechnology Holdings Inc stock?
John S. Kovach9.25%1,540,183$1.09MInsider
Glenn Krinsky8.85%1,474,998$1.05MInsider
Gil Schwartzberg7.06%1,176,388$835.24kInsider
Robert 1. Greenberg5.97%994,299$705.95kInsider
Ethos Financial Group LLC1.49%248,084$176.14kInstitution
Rene Bernards0.90%150,000$106.50kInsider
Philip F. Palmedo0.64%107,056$76.01kInsider
Geode Capital Management LLC0.61%101,209$71.86kInstitution
Stephen J. Forman0.45%74,804$53.11kInsider
Morgan Stanley0.43%71,054$50.45kInstitution

1 of 3

LIXT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LIXT3.27%33.77%Net Buying
SONN26.59%18.83%Net BuyingNet Buying
DOMH11.89%83.98%Net BuyingNet Buying
NMTR2.73%97.27%Net BuyingNet Selling

Lixte Biotechnology Holdings Stock Ownership FAQ

Who owns Lixte Biotechnology Holdings?

Lixte Biotechnology Holdings (NASDAQ: LIXT) is owned by 3.27% institutional shareholders, 33.77% Lixte Biotechnology Holdings insiders, and 62.96% retail investors. John S. Kovach is the largest individual Lixte Biotechnology Holdings shareholder, owning 1.54M shares representing 9.25% of the company. John S. Kovach's Lixte Biotechnology Holdings shares are currently valued at $1.09M.

If you're new to stock investing, here's how to buy Lixte Biotechnology Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.